Poor Manufacturing: Dr Reddy's, Sun Pharma, Aurobindo Recall Products In US
Poor Manufacturing: Dr Reddy's, Sun Pharma, Aurobindo Recall Products In US.
Stay updated with breaking news from Sun Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Poor Manufacturing: Dr Reddy's, Sun Pharma, Aurobindo Recall Products In US.
The week may remain lacklustre on the data front as no major economic data releases are scheduled in both the US as well as the Indian market. Indian investors are likely to focus more on the ongoing earnings season as well as stock specific developments. Nifty and Sensex have reached all-time highs driven by US Fed data and expert insights. Key factors that will shape market outlook.
Irrespective of who forms government at the Centre, sectors such as FMCG, auto, healthcare, IT services, private banks, and capital goods are expected to perform well, stated brokerage Prabhudas Lilladher in its latest report, 'India Strategy Report - Mandate 2024, Brace of Volatility'.
Read more about Dr Reddy's, Sun Pharma, Aurobindo recall products in US on Devdiscourse
These drug makers are recalling products due to manufacturing issues, as per the USFDA.